SIRT3 and neoplasm: However, in HCCs, SIRT3 acts as a tumor suppressor, as it mitigates ROS-induced hepatocellular injury and interacts with glycogen synthase kinase 3 beta (GSK-3β) to induce Bax translocation to the mitochondria, causing apoptosis [67].